Zuo, G., Gao, Y., Chen, W., & Chen, W. (2025). EE351 Cost-Utility Analysis of Sequential Therapy of iCT IRd and DRd strategy for Newly Diagnosed Multiple Myeloma Patients Who are Transplant-Ineligible in China. Value in health, 28(6), S126-S127. https://doi.org/10.1016/j.jval.2025.04.1950
Citácia podle Chicago (17th ed.)Zuo, Genyong, Yongbo Gao, Wendong Chen, a Wenming Chen. "EE351 Cost-Utility Analysis of Sequential Therapy of ICT IRd and DRd Strategy for Newly Diagnosed Multiple Myeloma Patients Who Are Transplant-Ineligible in China." Value in Health 28, no. 6 (2025): S126-S127. https://doi.org/10.1016/j.jval.2025.04.1950.
Citácia podľa MLA (8th ed.)Zuo, Genyong, et al. "EE351 Cost-Utility Analysis of Sequential Therapy of ICT IRd and DRd Strategy for Newly Diagnosed Multiple Myeloma Patients Who Are Transplant-Ineligible in China." Value in Health, vol. 28, no. 6, 2025, pp. S126-S127, https://doi.org/10.1016/j.jval.2025.04.1950.